To: StockDung who wrote (546 ) 4/8/2003 12:32:25 PM From: afrayem onigwecher Read Replies (1) | Respond to of 609 TTRE US: StockDiagnostics.com Reiterates TTR Technologies' O 2003-04-08 11:20 (New York) TTR TECHNOLOGIES INC ("TTRE-L") - StockDiagnostics.com Reiterates TTR Technologies' OPS Rating of "8" StockDiagnostics.com announced that it has reiterated its OPS Rating of "8" for TTR Technologies Inc (OTC:TTRE). TTR Technologies has had an OPS Rating of "8" for twenty-one consecutive quarters. StockDiagnostics.com's maintaining of the OPS RatingTM is based on TTR Technologies' recently filed Cash Flow Statements for its quarter ended December 31, 2002. The company's computed OPS TM (Operational-cashflow Per Share) for the quarter was $-0.05 per share as compared to $-0.05 per share for the comparable year earlier quarter. OPS for the most recent 12 months ended December 31, 2002 was $-0.23 per share as compared to $-0.18 per share for the 12 months ended December 31, 2001. OPS for TTR Technologies' trailing twelve months reached a three year low. The shares of TTR Technologies were recently trading at $0.38. About OPS RatingsTM -- StockDiagnostics.com monitors a public company's Operational cash flow Per Share ("OPS") and assigns it an "OPS Rating", which measures the long term risk associated with a company's ability to remain in business. A company's "OPS" logically falls into a mathematical sequence that ranks it into one of eight distinctive "risk" categories. Each of the categories is based on a company's operating cash flow for each of its last 4 quarters and its cumulative operating cash flow for its most recent 12 months. OPS Ratings are upgraded, downgraded or reiterated each time a company files a quarterly report and at any time that its financial statements are amended. Statistical research on OPS Ratings is available at stockdiagnostics.com . About StockDiagnostics.com -- StockDiagnostics.com has a proprietary data refinery that automates the process of collecting, sorting and organizing large amounts of securities pricing and financial data into comparative financial ratios. These ratios are used to identify Financial Statement anomalies and securities pricing variances to monitor changes in the performance of public companies. Go tostockdiagnostics.com for a description of StockDiagnostics.com's patent-pending technical applications, such as OPS, OPS Ratings, The EPS Syndrome and more. Full details are available atstockdiagnostics.com . ______________________________________ ___________________________________________________________________ (c) Market News Publishing Inc. Tel:(604) 689-1101 All rights reserved. Fax:(604) 689-1106 MarketbyFax(tm) - To get the NEWS as it happens, call (604) 689-3041. Provider ID: 00000260 -0- Apr/08/2003 15:20 GMT